The company that manufactured the opioid drug OxyContin, Purdue Pharma, announced on Tuesday, July 27th, that is creditors voted to support a proposed bankruptcy deal to settle thousands of lawsuits against the drug manufacturer, which in turn shields the family that owns Perdue Pharma, the billionaire Sacklers, from further litigation over its role in creating America’s current opioid epidemic. According to the company, “More than 95% of the 120,000-plus votes submitted” were in favor of the bankruptcy deal. Many people directly blame the Sacklers and Perdue Pharma for creating and fueling the opioid crisis in the United States and were outraged at a potential bankruptcy agreement that would shield the Sacklers from further litigation. For many people, this was an easy off-the-hook for the billionaire family. However, if the proposed bankruptcy deal is successful, the settlement with Perdue Pharma will see assets, money, and medication for the treatment of opioid addiction and overdose reversal medications like Narcan and naloxone distributed to communities across the country. The settlement would also cover personal injury claims against Perdue Pharma.